Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretreatment of patients expecting bariatric surgery with the GLP-1 analog Liraglutide
DRKS00004203Phase 4Recruiting
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- May 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and type 2 diabetes mellitus (T2DM) comparing Liraglutide (Victoza) pretreatment with Placebo pretreatment (2 arms). Primary endpoint: Change in subcutaneous adipose tissue parameters after liraglutide pretreatment. Started May 2015; status: recruiting.
02
Drugs
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00004203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004203.